-+ 0.00%
-+ 0.00%
-+ 0.00%

PMV PHARMACEUTICALS, - REZATAPOPT SHOWS FAVORABLE SAFETY PROFILE WITH 5% DISCONTINUATION RATE DUE TO ADVERSE EVENTS

Reuters·08/31/2026 20:01:00

Please log in to view news